- Home
- FBIZ vs TERN Comparison
FBIZ vs TERN Comparison
Compare FBIZ & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIZ
- TERN
- Stock Information
- Founded
- FBIZ 1909
- TERN 2017
- Country
- FBIZ United States
- TERN United States
- Employees
- FBIZ N/A
- TERN N/A
- Industry
- FBIZ Major Banks
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- FBIZ Finance
- TERN Health Care
- Exchange
- FBIZ Nasdaq
- TERN Nasdaq
- Market Cap
- FBIZ 396.0M
- TERN 321.4M
- IPO Year
- FBIZ N/A
- TERN 2021
- Fundamental
- Price
- FBIZ $50.87
- TERN $3.80
- Analyst Decision
- FBIZ Strong Buy
- TERN Buy
- Analyst Count
- FBIZ 4
- TERN 5
- Target Price
- FBIZ $57.25
- TERN $15.63
- AVG Volume (30 Days)
- FBIZ 53.8K
- TERN 932.0K
- Earning Date
- FBIZ 07-24-2025
- TERN 08-04-2025
- Dividend Yield
- FBIZ 2.27%
- TERN N/A
- EPS Growth
- FBIZ 26.78
- TERN N/A
- EPS
- FBIZ 5.48
- TERN N/A
- Revenue
- FBIZ $148,866,000.00
- TERN N/A
- Revenue This Year
- FBIZ $18.39
- TERN N/A
- Revenue Next Year
- FBIZ $7.81
- TERN N/A
- P/E Ratio
- FBIZ $9.32
- TERN N/A
- Revenue Growth
- FBIZ 9.38
- TERN N/A
- 52 Week Low
- FBIZ $35.25
- TERN $1.87
- 52 Week High
- FBIZ $56.46
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- FBIZ 58.45
- TERN 61.74
- Support Level
- FBIZ $48.73
- TERN $3.66
- Resistance Level
- FBIZ $50.31
- TERN $4.30
- Average True Range (ATR)
- FBIZ 1.04
- TERN 0.31
- MACD
- FBIZ 0.19
- TERN -0.01
- Stochastic Oscillator
- FBIZ 81.40
- TERN 59.28
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.